Driving proactive diagnoses and effective treatment with voice AI.
Canary Speech’s proprietary technology models mood, disease states, and clinical deterioration using digital vocal biomarkers. Our technology provides clinical-grade insight into patient wellness and proactive health screening.
A fundamental struggle with budget, diagnosis, and drug adherence.
Patients receive little support from clinicians and pharmacists after receiving a diagnosis. As little as half of mental health patients successfully adhere to a medication regimen, of the small percentage who are successfully diagnosed. Pharmaceutical budget is largely allocated to clinical trials and directed away from patient care and actionable insight into patient wellness or telemedicine solutions.
Shaping the future of the pharmaceutical industry with voice analytics.
Canary Speech’s technology represents a fundamental shift in how the pharmaceutical industry is able to screen patients, provide care, and develop medication. Our objective, actionable vocal biomarker data powers more effective patient diagnoses and ensures patients get access to life-changing medication.
Real-time monitoring ensures seamless wellness tracking, and ability to assess medication adherence remotely and non-invasively.
Explore Use Cases
Driving objective, scalable data solutions in telehealth for more successful patient outcomes.
Coordinating stakeholders to streamline clinical trials with cost-effective, non-invasive data collection.
Aging in Place
Providing dignified, accessible healthcare using objective, actionable data for aging patients.